Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
platinum-based antineoplastic agent |
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:CASNumber |
671881-26-8
|
| gptkbp:chemicalFormula |
C6H9N3O2Pt
|
| gptkbp:clinicalTrialPhase |
Phase III (as of 2010s)
|
| gptkbp:developedBy |
antineoplastic agent
|
| gptkbp:developer |
gptkb:Poniard_Pharmaceuticals
|
| https://www.w3.org/2000/01/rdf-schema#label |
picoplatin
|
| gptkbp:IUPACName |
(SP-4-2)-Ammonia dichloro(2-methylpyridine)platinum(II)
|
| gptkbp:mechanismOfAction |
DNA crosslinking
|
| gptkbp:molecularWeight |
397.24 g/mol
|
| gptkbp:relatedTo |
gptkb:carboplatin
gptkb:oxaliplatin gptkb:cisplatin |
| gptkbp:synonym |
AMD473
|
| gptkbp:target |
gptkb:cancer
colorectal cancer prostate cancer Small Cell Lung Cancer |
| gptkbp:bfsParent |
gptkb:PNT2003
|
| gptkbp:bfsLayer |
8
|